Depatuxizumab mafodotin
Overview[edit]
Depatuxizumab mafodotin is an antibody-drug conjugate (ADC) designed for the treatment of certain types of cancer. It combines a monoclonal antibody targeting the epidermal growth factor receptor (EGFR) with a potent cytotoxic agent, mafodotin, which is a derivative of the microtubule-disrupting agent monomethyl auristatin F (MMAF).
Mechanism of Action[edit]
Depatuxizumab mafodotin works by specifically targeting and binding to EGFR, which is overexpressed in various tumors. Upon binding, the ADC is internalized by the cancer cell, where the cytotoxic agent mafodotin is released. This agent disrupts the microtubule network within the cell, leading to cell cycle arrest and apoptosis.
Development and Clinical Trials[edit]
Depatuxizumab mafodotin has been evaluated in several clinical trials for its efficacy and safety in treating glioblastoma and other EGFR-expressing tumors. The results have shown promise, particularly in patients with recurrent glioblastoma.
Side Effects[edit]
The administration of depatuxizumab mafodotin can lead to various side effects, including ocular toxicity, fatigue, and hematologic toxicity. These side effects are primarily due to the action of the cytotoxic agent mafodotin.
Image Gallery[edit]
Related pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
